The most advanced vaccine for dengue only offers modest protection but could still help millions of people avoid the devastating effects of the disease known as "breakbone fever," according to a large trial.
Galderma S.A. announced that it has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International, Inc. The expansion into aesthetic and corrective dermatology in the U.S. and Canada completes Galderma's global skin health footprint and extends its leadership in aesthetic medicine worldwide.
Neurelis has announced an agreement with Biotie Therapies to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 for pediatric and adult epilepsy patients who experience acute repetitive seizures.
ScinoPharm announced that after 17 years of dedicated service, its co-founder and President & CEO Dr. Jo Shen is retiring at the end of July 2014 and will be succeeded by Dr. Yung-Fa (Fred) Chen, currently Sr. Vice President of R&D and Chief Technology Officer, effective August 1, 2014.
If you’re currently planning on implementing a Manufacturing Execution System (MES) or other applications in the Manufacturing Operations Management (MOM) space, you may think you have all the shop-floor areas and situations that still use manual, paper-based processes identified, but this may not necessarily be the case.
More "headline-grabbing" acquisitions are likely over the coming year as businesses take advantage of a period of improving economic growth and cheap financing. That's the conclusion of business consulting firm EY, which says the value of takeover deals announced in the first half of 2014 struck its highest level since the end of the boom years in 2007.
A World Health Organization official on Thursday urged millions of Muslims making the pilgrimage to Mecca, Saudi Arabia, to exercise basic hygiene as mass gatherings pose risks of spreading the Middle East respiratory syndrome.
Bad reactions to psychiatric drugs result in nearly 90,000 emergency room visits each year by U.S. adults, with anti-anxiety medicines and sedatives among the most common culprits, a study suggests.
Bristol-Myers Squibb Company today announced that, following discussions with the FDA, the company is planning a third quarter submission of a Biologics Licensing Application (BLA) for Opdivo® (nivolumab) for previously treated advanced melanoma.
Vertex Pharmaceuticals Incorporated today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 years with the company.
Arena Pharmaceuticals, reported that Eisai Inc. has completed its planned increase of more than 200 new contract sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ by 50% to approximately 600.
Nearly 95 percent of U.S. physicians accept gifts, meals, payments, travel and other services from companies that make the drugs and medical products they prescribe, according to the New England Journal of Medicine.
Review of ADHD Drug Approvals Highlights Gaps between Pediatric Approval Process and Long-Term Safety AssessmentJuly 9, 2014 2:14 pm | News | Comments
Over the last 60 years, the FDA approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS ONE.
Introducing the CMSX, the first in a new generation of process industry closed loop position controllers for quarter turn actuators.